[1] |
ZHU Li, WEI Bing, LIAO Shi'e, ZHANG Chao, ZHENG Xiaoyu, LIU Yajun.
Effects of single nucleotide polymorphism of drug metabolizing enzyme cytochrome P450 on the efficacy of inhaled cortisol hormone in asthmatic children
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 536-543.
|
[2] |
SHI Dawei, ZHENG Xiaoyong, JIN Xiaodan, ZHAO Xiaoman, CHEN Jie, DU Xingjun.
Implication of XPC rs2228001 polymorphism on the prognosis of patients with colorectal cancer who were treated with capecitabine-based adjuvant chemotherapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 391-399.
|
[3] |
WU Yi, FANG Fang, CHEN Ying, Fan Junwei.
Influence of donor and recipient CYP3A5 genotype on tacrolimus trough concentrations in the early stage after liver transplantation and its clinical significance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 631-639.
|
[4] |
XIA Chunyong, ZHANG Zuowen, HE Xiaoyan, LIU Jie, LI Xiaoya, CHANG Qiuhong, QIN Lijuan, CAO Zhenming, DING Ling.
Correlation between CYP2C19 gene polymorphism and individualized medication in patients with ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 318-323.
|
[5] |
XU Honglei, XU Bingxin, ZU Qing, ZHAO Yan, GAO Pengfei, YU Yang.
Effects of CYP2C19 gene polymorphism on the clinical prognosis of clopidogrel in elderly patients with acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1014-1020.
|
[6] |
PENG Jing, LIU Jun, XU Huifang, LI Yueran, JIANG Jia, WANG Sheng, ZHOU Dexi, ZHU Yanhong, YANG Kui, LUAN Jiajie.
Correlation study between cytochrome P4502C19 gene polymorphism or metabolic type and ADP induced-platelet aggregation inhibition and clopidogrel resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 746-751.
|
[7] |
WU Qiaoyu, YUAN Hong, LU Yao.
Evaluation of the effects of resveratrol on the activity human cytochrome P450 through combined probe method
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 426-432.
|
[8] |
WU Maofeng, LIU Chang, DAI Huihui, MAI Zhangfeng, HUANG Danli, MIAO Jingwei, LIU Lizhong, FANG Yi.
Preliminary association of individual different plasma pazopanib concentration with CYP3A4 gene polymorphism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1376-1380.
|
[9] |
WAN Ping, LIU Liang, ZHANG Ping, ZHANG Zhongdong.
Influential factors of serum concentration/dosage ratio for schizophrenia patients after oral administration of olanzapine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1024-1029.
|
[10] |
YANG Rui, LIU Hui, CHEN Zeheng, QI Tingting,ZHANG Zanling, QU Qiang.
Clinical pharmacists use CYP2C19 genotyping test to guide individual medication therapy of Clopidogrel and to evaluate the efficacy of treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 938-943.
|
[11] |
WANG Ente, ZHANG Xiaodan, ZHOU Shuang, ZHAO Xia, ZHOU Ying, CUI Yimin.
Effects of genetic polymorphisms on metabolic kinetics, pharmacodynamics and adverse reactions of amitriptyline
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 235-240.
|
[12] |
PENG Qiuju, YAN Huacheng, SHI Lei.
Advances in the relationship between cytochrome P450 SNP and susceptibility to coronary heart disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 477-480.
|
[13] |
ZHOU Jianhua, LIU Kelan, WU Ganbin.
Effects of anti-platelet individual treatment guided by CYP2C19 polymorphism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1364-1367.
|
[14] |
ZHANG Peiyu, REN Jing, ZHI Wenqian, LIU Chengming, GAO Na.
Inhibition of CYP450 activity by honokiol and other four components of Chinese traditionalmedicine in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 922-926.
|
[15] |
WANG Ying-ying, CHENG Guang-hua, PU Zhi-chen, GE Jun-liang, XIE Yan, CHEN Xiao-lei.
Association between CYP2D6*10/CYP2C19*2 genotype polymorphism and survival of breast cancer patients receiving tamoxifen treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 552-556.
|